ANNX

Annexon, Inc. ANNX

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Pending next ranking run

This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Net income

$-55.35M

Quarter to Jun 30

Free cash flow

$-48.14M

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$1.02B total
FMR LLC
$111.45M+83.5%
BlackRock, Inc.
$77.31M+23.8%
Redmile Group, LLC
$67.78M-18.4%
STATE STREET CORP
$56.10M+42.0%
BVF INC/IL
$49.67M0.0%
Woodline Partners LP
$39.54M+196.3%
VANGUARD CAPITAL MANAGEMENT LLC
$39.23M+15.4%
MAK CAPITAL ONE LLC
$33.47M+24.1%
GOLDMAN SACHS GROUP INC
$33.26M+170.6%
Siren, L.L.C.
$25.46M+12.6%
Bain Capital Life Sciences Investors, LLC
$25.34M-14.9%
Bellevue Group AG
$23.41M-20.5%
GEODE CAPITAL MANAGEMENT, LLC
$23.06M+19.5%
MPM BioImpact LLC
$20.24MNew
AMERIPRISE FINANCIAL INC
$20.04M+1.8%
ADAGE CAPITAL PARTNERS GP, L.L.C.
$19.98M-18.6%
GREAT POINT PARTNERS LLC
$19.98M+40.0%
MORGAN STANLEY
$17.95M+14.9%
Palo Alto Investors LP
$16.83M0.0%
BALYASNY ASSET MANAGEMENT L.P.
$16.16M-27.2%
Nuveen, LLC
$15.79M-34.9%
Qube Research & Technologies Ltd
$15.70M-11.7%
VANGUARD PORTFOLIO MANAGEMENT LLC
$12.83M+51.5%
Opaleye Management Inc.
$9.79M-26.5%
Logos Global Management LP
$8.56MNew
See all 217 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Free Cash Flow

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/ANNX

Earnings Per Share

13fpro.ai/company/ANNX

Loading ratio trend…

ANNX insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Annexon, Inc. (ANNX): stock profile, AI score and financials

Annexon, Inc. (ANNX) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. ANNX is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Based on the latest XBRL financial filings (Q2 2026), Annexon, Inc. reports net income of $-55.3M, free cash flow of $-48.1M. Top institutional holders of ANNX by reported 13-F value include FMR, BlackRock, Redmile Group, based on the most recent SEC filings. ANNX trades on the Nasdaq exchange and files with the SEC under CIK 1528115. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ANNX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Annexon, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1528115 →